3Negi PC, Bhardwaj R, Kandoria A, et al. Epidemiological study of hy- pertension in natives of Spiti Valley in Himalayas and impact of hypo- baric hypoxemia; a cross-sectional study[ J]. Assoc Physicians India, 2012,60(6) :21-25.
4Strum EJ Jr, Isner RJ, Malan TP Jr, et al. Sevoflurane degradation product concentrations with soda lime duringprolonged anesthesia [ J ]. J Clinical Anesthesia, 1994,6 ( 3 ) : 239 -242.
5刘俊杰,赵俊,主编,现代麻醉学[M].第3版,北京:人民卫生出版社,2003,40
6Liu XS, Xue QS, Zeng Qw, et al. Sevoflurane impairs memory consoli- dationin rats, possibly through inhibiting phosphorylation of glycogen synthasekinase-3 beta in the hippocampus[ J]. Neurobiol Learn Mere, 2010,94 (4) :461-467.
5PHAM H, ARMSTONG D G, HARVEY C, et al. Screening techniques to identidy people at high risk for diabetic foot ulceration [J]. Diabetes Care, 2000, 23 (3) : 606 - 611.
6GOODING G A W, STESS R N, GRAF P M, et al. Sonography of the sole of the foot: evidence for loss of foot pad thickness in diabetes and its relationship to ulceration of the foot [J]. Invest Radiol, 1986, 21(1) :45 -46.
7MACFARLANE R N, JEFFCORE W J. Factors contributing to the drcsentation of the siabetlc foot ulcers [J]. Diabetic Med, 1997, 14(10) : 867 - 870.
8WAGNER F W, Jr, The dysvascular foot: a system for diagnosisand treatment [J]. Foot Ankle, 1981, 2(2) :64 - 122.
9盛正妍.Ⅱ型糖尿病的分期治疗及临床处理评价[J].实用糖尿病学杂志,1998,2:10-10.
10Wanger JR. Transcutaneous doppler ultrasound in the prediction of healing and the selection of surgical level for dysvascular lesion of the toes and forefoot[J]. Clin Orth Rela Res,1979,142:110.
